Avenda Health competed in FOCAL 2020: Focal Therapy Gauntlet, attended by top urologists from around the country. Avenda Health received the top award and was voted the “Most Promising Ablative Technology.” The support of so many urologists further propels Avenda Health forward as they aim to bring a focal therapy for the treatment of prostate cancer to the market.
